Ryan James Darling,Craig Duane Dickinson,David Albert Driver,Malgorzata Donata Gonciarz
申请号：
US13910149
公开号：
US08741841B2
申请日:
2013.06.05
申请国别(地区):
US
年份:
2014
代理人:
摘要：
This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) proteins, pharmaceutical compositions comprising FGF21 proteins, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such proteins.
